ProstaLund AB (publ) (PLUN.ST)
- Previous Close
6.95 - Open
7.75 - Bid 6.95 x --
- Ask 7.45 x --
- Day's Range
6.90 - 7.75 - 52 Week Range
4.84 - 46.13 - Volume
101 - Avg. Volume
5,875 - Market Cap (intraday)
25.006M - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-6.94 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
prostalund.se9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PLUN.ST
View MorePerformance Overview: PLUN.ST
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLUN.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLUN.ST
View MoreValuation Measures
Market Cap
25.19M
Enterprise Value
18.30M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.65
Price/Book (mrq)
0.46
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-164.89%
Return on Assets (ttm)
-22.11%
Return on Equity (ttm)
-40.97%
Revenue (ttm)
13.72M
Net Income Avi to Common (ttm)
-22.63M
Diluted EPS (ttm)
-6.94
Balance Sheet and Cash Flow
Total Cash (mrq)
7.82M
Total Debt/Equity (mrq)
1.69%
Levered Free Cash Flow (ttm)
-21.42M